Yang Ding
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Biomaterials 32
- Nanoparticle-Based Drug Delivery 28
-
- Nanoplatforms for cancer theranostics 28
- Graphene and Nanomaterials Applications 6
- Co-authors
- Liping Wei (1 shared paper)Shan Dong (1 shared paper)Jiaju Huang (1 shared paper)Ge Gao (1 shared paper)Lei Kong (1 shared paper)Chen Xie (1 shared paper)Xizeng Mao (1 shared paper)Chuan‐Yun Li (1 shared paper)
- Journals
- Biomaterials (11 papers)Journal of Controlled Release (7 papers)Advanced Science (5 papers)Biomaterials Science (5 papers)Advanced Functional Materials (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yang Ding
106 papers receiving 7.5k citations
Yang Ding's Hit Papers
Peers
Comparison fields: 5 of 151
- Biomaterials 825
- Cancer Research 748
- Molecular Biology 3.2k
- Pharmaceutical Science 276
- Biological Psychiatry 99
Countries citing papers authored by Yang Ding
This map shows the geographic impact of Yang Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Ding more than expected).
Fields of papers citing papers by Yang Ding
This network shows the impact of papers produced by Yang Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Ding. The network helps show where Yang Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases Hit paper breakdown → | 2011 | 4058 |
| 2 | 2016 | 228 | |
| 3 | 2021 | 177 | |
| 4 | 2016 | 134 | |
| 5 | 2012 | 119 | |
| 6 | 2021 | 107 | |
| 7 | 2014 | 105 | |
| 8 | 2018 | 97 | |
| 9 | 2006 | 95 | |
| 10 | 2014 | 86 | |
| 11 | 2020 | 85 | |
| 12 | 2018 | 83 | |
| 13 | 2017 | 76 | |
| 14 | 2021 | 73 | |
| 15 | 2021 | 67 | |
| 16 | 2022 | 64 | |
| 17 | 2018 | 64 | |
| 18 | 2020 | 64 | |
| 19 | 2009 | 62 | |
| 20 | 2017 | 59 |
About Yang Ding
Yang Ding is a scholar working on Biomaterials, Biomedical Engineering, Pharmaceutical Science, Molecular Biology and Physiology, having authored 113 papers that have together received 7.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (28 papers), Nanoplatforms for cancer theranostics (28 papers), RNA Interference and Gene Delivery (20 papers), Advanced biosensing and bioanalysis techniques (13 papers), Alzheimer's disease research and treatments (7 papers), Graphene and Nanomaterials Applications (6 papers), Extracellular vesicles in disease (6 papers) and Advanced Drug Delivery Systems (5 papers). The work is most often cited by research in Biomaterials (825 citations), Cancer Research (748 citations), Molecular Biology (3.2k citations), Pharmaceutical Science (276 citations) and Biological Psychiatry (99 citations). Yang Ding has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Liping Wei, Shan Dong, Jiaju Huang, Ge Gao, Lei Kong, Chen Xie, Xizeng Mao, Chuan‐Yun Li, Jianmin Wu and Jianping Zhou. Their work appears in journals such as Biomaterials, Journal of Controlled Release, Advanced Science, Biomaterials Science and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.